Noa Gordon
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Colorectal Cancer Surgical Treatments 4
- Cancer Immunotherapy and Biomarkers 3
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Daniel A. Goldstein (16 shared papers)Salomon M. Stemmer (12 shared papers)Assaf Moore (15 shared papers)Michal Sarfaty (12 shared papers)Moshe Leshno (6 shared papers)Dan Greenberg (4 shared papers)Victoria Neiman (5 shared papers)Eli Rosenbaum (5 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Radiation Oncology (3 papers)Head & Neck (2 papers)PLoS ONE (2 papers)Journal of Cancer (2 papers)
- Partner nations
- IsraelUnited StatesCanada
In The Last Decade
Noa Gordon
40 papers receiving 582 citations
Peers
Comparison fields: 5 of 67
- Hepatology 59
- Oncology 162
- Pulmonary and Respiratory Medicine 121
- Economics and Econometrics 93
- Otorhinolaryngology 10
Countries citing papers authored by Noa Gordon
This map shows the geographic impact of Noa Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Gordon more than expected).
Fields of papers citing papers by Noa Gordon
This network shows the impact of papers produced by Noa Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Gordon. The network helps show where Noa Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Noa Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 82 | |
| 2 | 2017 | 81 | |
| 3 | 2017 | 58 | |
| 4 | 2017 | 55 | |
| 5 | 2018 | 53 | |
| 6 | 2015 | 31 | |
| 7 | 2019 | 28 | |
| 8 | 2012 | 28 | |
| 9 | 2020 | 24 | |
| 10 | 2019 | 15 | |
| 11 | 2018 | 12 | |
| 12 | 2021 | 11 | |
| 13 | 2018 | 11 | |
| 14 | 2014 | 10 | |
| 15 | 2019 | 10 | |
| 16 | 2021 | 7 | |
| 17 | 2015 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2012 | 6 | |
| 20 | Splenectomy and the induction of cancer of the colon in rats. | 1988 | 6 |
About Noa Gordon
Noa Gordon is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 591 indexed citations. Recurring topics across this work include Economic and Financial Impacts of Cancer (5 papers), Pharmaceutical Economics and Policy (4 papers), Esophageal Cancer Research and Treatment (4 papers), Colorectal Cancer Surgical Treatments (4 papers), Gastric Cancer Management and Outcomes (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (59 citations), Oncology (162 citations), Pulmonary and Respiratory Medicine (121 citations), Economics and Econometrics (93 citations) and Otorhinolaryngology (10 citations). Noa Gordon has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Daniel A. Goldstein, Salomon M. Stemmer, Assaf Moore, Michal Sarfaty, Moshe Leshno, Dan Greenberg, Victoria Neiman, Eli Rosenbaum, Miri Yemini and Yulia Kundel. Their work appears in journals such as Journal of Clinical Oncology, Radiation Oncology, Head & Neck, PLoS ONE and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.